Journal profile · Neurosciences
Experimental Neurology
ISSN 0014-4886 · eISSN 1090-2430 · Academic Press Inc. · UNITED STATES · Monthly · Founded 1959
Experimental Neurology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.78; hybrid open access; APC about USD 4,110; median 108 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 399 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Experimental Neurology is published by Academic Press Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Nerve injury and regeneration and Neurogenesis and neuroplasticity mechanisms, together about 33.2% of its articles. Its main subfields are Cellular and Molecular Neuroscience and Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Experimental Neurology publishes original research in the area of neuroscience with a focus on research concerning basic mechanisms underlying neurological disorders.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.
From the journal's Aims & Scope
Research area (LetPub): Neurosciences
Editor-in-chief Midori YenariPublisher website
Editorial board by country: 12 in mainland China (about 11%); most named United States 63, Mainland China 12, Germany 10, Canada 6, Japan 4 (114 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience14.1%
- Nerve injury and regenerationNeuroscience10.3%
- Neurogenesis and neuroplasticity mechanismsNeuroscience8.7%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience5.5%
- Pain Mechanisms and TreatmentsMedicine4.6%
- Spinal Cord Injury ResearchMedicine4.4%
- Neuroscience and Neural EngineeringNeuroscience4.3%
- Neural dynamics and brain functionNeuroscience4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.78LetPub ·
- Impact factor (publisher)
- 4.8Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- SJR 2026-06
- 1.39LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 168LetPub ·
- h-index
- 274OpenAlex ·
- i10-index
- 12,267OpenAlex ·
- 2-year mean citedness
- 4.04OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 25.38%LetPub ·
Volume
- Articles per year
- 338LetPub ·
Articles by year OpenAlex count · 16,740 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 337 | 107 | 139 |
| 2025 | 399 | 165 | 1,214 |
| 2024 | 376 | 174 | 3,140 |
| 2023 | 252 | 106 | 3,811 |
| 2022 | 242 | 128 | 4,797 |
| 2021 | 291 | 137 | 7,900 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
108 daysMedian, submission to acceptance · P25–P75 79 days – 149 days
- Acceptance to online
- median 2 days (98 articles)
- Submission to online
- median 112 days
- Sample
- 98 articles with submission and acceptance dates (890 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 103 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,110 / EUR 3,840 / GBP 3,290 / JPY 509,760 | — | — | |
| Publisher website | USD 3,850 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,000 words
- Highlights
- Required
Article types accepted11, with length limits
- brief communicationResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…Length not stated
- brief communicationsBrief Communications — these should be reserved for manuscripts that are very novel and timely.Length not stated
- commentariesCommentaries - the Journal publishes invited commentaries up to a maximum of 3000 words on published articles.Length not stated
- commentaryResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…main text ≤ 3,000 words
- perspectiveResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…Length not stated
- research articleResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…Length not stated
- research articlesResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases.Length not stated
- reviewResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…main text ≤ 6,000 words
- review articleResearch Articles — the Journal publishes Research Articles focusing on experimental models of neurological and psychiatric diseases. These should describe sign…Length not stated
- review articlesReview Articles - these are exhaustive reviews on a specific topic of neuroscience.Length not stated
- special issuesSpecial Issues - The journal welcomes proposals for special issues on topics that fall within the scope of the journal.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1959
- ISSN
- 0014-4886
- Electronic ISSN
- 1090-2430
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Experimental Neurology
What CAS zone is Experimental Neurology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Experimental Neurology is in Zone 2 of Medicine, and in Zone 2 of the minor category Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Experimental Neurology?
The latest impact factor listed by LetPub is 4.78; CiteScore 8, h-index 274.
How long does peer review take at Experimental Neurology?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 79–149 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Experimental Neurology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 3,000 words; Highlights: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Experimental Neurology based?
Of the 114 board members whose country the journal's board page names, 12 (about 11%) are in mainland China; the countries named most often are United States (63), Mainland China (12) and Germany (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Experimental Neurology?
According to LetPub and DOAJ records, Experimental Neurology is indexed in SCIE and Scopus.
Is Experimental Neurology open access, and what is the APC?
Experimental Neurology is a hybrid journal. For open-access publication: APC about USD 4,110.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .